Cargando…
Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation
BACKGROUND: The HIV-1 nucleoside RT inhibitor (NRTI)-resistance mutation, K65R confers intermediate to high-level resistance to the NRTIs abacavir, didanosine, emtricitabine, lamivudine, and tenofovir; and low-level resistance to stavudine. Several lines of evidence suggest that K65R is more common...
Autores principales: | Varghese, Vici, Wang, Elijah, Babrzadeh, Farbod, Bachmann, Michael H., Shahriar, Rajin, Liu, Tommy, Mappala, Svetlana Jean M., Gharizadeh, Baback, Fessel, W. Jeffrey, Katzenstein, David, Kassaye, Seble, Shafer, Robert W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881873/ https://www.ncbi.nlm.nih.gov/pubmed/20539818 http://dx.doi.org/10.1371/journal.pone.0010992 |
Ejemplares similares
-
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance
por: Babrzadeh, Farbod, et al.
Publicado: (2013) -
Next Generation Gene Synthesis by targeted retrieval of bead-immobilized, sequence verified DNA clones from a high throughput pyrosequencing device
por: Matzas, Mark, et al.
Publicado: (2010) -
Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review
por: Rhee, Soo-Yon, et al.
Publicado: (2022) -
Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors
por: Manasa, Justen, et al.
Publicado: (2017) -
Viral Population Estimation Using Pyrosequencing
por: Eriksson, Nicholas, et al.
Publicado: (2008)